Navigation Links
Intellectual Property Lawyer Available for Comment on Recent Supreme Court Ruling

BUFFALO, N.Y., March 23, 2012  /PRNewswire/ -- Jeremy P. Oczek, a registered patent attorney and Member in the Intellectual Property and Technology Group of Bond Schoeneck & King, is available to comment on the recent Supreme Court ruling that has significant implications for the medical and biotechnology industries.

In Mayo Collaborative Services v. Prometheus Labs, Inc., the Court unanimously ruled that a medicine dosing process that merely describes a "natural law" is not eligible for patent protection. Writing for the Court, Justice Stephen G. Breyer said Prometheus Laboratories' medical tests, designed to help doctors determine the most beneficial drug dosage by describing the correlation between metabolites in patients' blood and the likelihood that the dosage will be ineffective or harmful, were directed to laws of nature and therefore not eligible for patent protection. Justice Breyer cited Einstein's E=mc(2) formula and Newton's law of gravity as celebrated examples of natural laws that courts have long held are not patentable.

Mr. Oczek, a registered patent attorney in the Buffalo office of Bond, Schoeneck & King, PLLC, has litigated patent cases in federal courts throughout the United States. He has offered commentary on intellectual property issues for many national publications, including The National Law Journal, BNA's Patent, Trademark & Copyright Journal and Law360, and has published articles on intellectual property law in the Buffalo Law Journal, Sedona Conference Journal and Boston College Law Review.

Bond, Schoeneck & King, PLLC is a full-service law firm of more than 200 attorneys with offices in New York State, Kansas and Florida. For a complete list of practice areas and industries served, please visit

To arrange a phone interview with Mr. Oczek, please contact Kim Parr, Director of Public Relations at Latorra, Paul & McCann at (315) 476-1646, ext. 225 or email


Opinion by Justice Stephen G. Breyer:

New York Times: Justices Back Mayo Clinic Argument on Patents:

Wall Street Journal: Top Court's Patent Rejection Alarms the Biotech Industry:

Jeremy P. Oczek:

Bond, Schoeneck & King:

Kim Parr
Latorra, Paul & McCann
(315) 476-1646, ext. 225

SOURCE Bond Schoeneck & King
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. PharmacoFore, Inc. Announces Appointment of Chief Medical Officer and Vice President of Intellectual Property
2. Ontario Institute for Cancer Research Announces Enhancements to its Intellectual Property Development and Commercialization Program
3. iPierian Expands Leadership Team With Experienced Business Development and Intellectual Property Executives
4. China YCT International Group, Inc. Announces That the State Intellectual Property Office of the Peoples Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd.
5. BIO Ventures for Global Health Chosen to Administer the GSK and Alnylam Intellectual Property Pool
6. Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property
7. Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property
8. Veteran Intellectual Property Team Joins Brown Rudnick
9. EPIX Pharmaceuticals, Inc. Announces the PRX-00023 Therapeutics CNS Program in Phase 2b/3 Will Be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction
10. Epix Pharmaceuticals, Inc. Announces the PRX-08066 Therapeutics Program in Phase 2 for Respiratory Indication Will Be Part of The Intellectual Property Offered for Sale at the September 30, 2009 Auction
11. Hill-Rom Announces Sale of Negative Pressure Wound Therapy Intellectual Property
Post Your Comments:
(Date:12/1/2015)... DIEGO , Dec. 1, 2015  CardioCell ... uses allogeneic stem cells for cardiovascular indications, intends ... trial protocol based on recommendations from a Heart ... and its Scientific Advisory Board members . ... analyzed preliminary Phase IIa safety and efficacy data ...
(Date:12/1/2015)... , Dec. 1, 2015 Cepheid (Nasdaq: ... participation at the Piper Jaffray Healthcare Conference in ... the Company is reaffirming its outlook for the fourth ... in addition to discussing longer term business model expectations. ... Executive Officer.  "We continue to be the fastest growing ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... join physicians, aesthetic practitioners and aesthetics professionals from Central America and abroad for ... held in Panama City, Panama Feb. 17-19, 2016. Testart will present and discuss ...
(Date:11/30/2015)... MONTREAL , Dec. 1, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... that it has joined the American Business Act on Climate ... economy that are standing with the Obama Administration to demonstrate ... for a strong outcome to the COP21 Paris ... . --> Sarnia, Canada . ...
Breaking Biology Technology:
(Date:11/9/2015)... SAN JOSE, Calif. , Nov. 9, 2015 /PRNewswire/ ... of human interface solutions, today announced broader entry into ... of vehicle-specific solutions that match the pace of consumer ... drivers, and biometric sensors are ideal for the automotive ... the vehicle. Europe , ...
(Date:10/29/2015)... 2015  The J. Craig Venter Institute (JCVI) policy ... and Biosecurity: Lessons Learned and Options for the Future," ... Human Services guidance for synthetic biology providers has worked ... --> --> Synthetic biology promises ... to pose unique biosecurity threats. It now is easier ...
(Date:10/29/2015)... 2015 NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... a leading marketplace to discover and buy innovative ... wallet on StackSocial for this holiday season.   ... "Company"), a biometric authentication company focused on the ...
Breaking Biology News(10 mins):